EMG
EVH icon

ETF Managers Group’s Evolent Health EVH Stock Holding History

ETF Managers Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,013
Closed -$102K – 469
2017
Q2 		$102K Buy
+4,013
New +$96.5K 0.01% 178
2016
Q1 		$34K Buy
+1,514
New +$15.6K 0.02% 247

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

ETF Managers Group's EVH Position: Q3 2017 in Review

ETF Managers Group sold out of Evolent Health (EVH) in Q3 2017, closing a stake of 4,013 shares — an estimated $102K sold.

ETF Managers Group first reported a position in EVH in Q1 2016 and held it in 2 quarters. The position peaked at $102K in Q2 2017. 166 funds tracked by Wall St. Rank hold EVH as of Q3 2017.

  • ETF Managers Group reported no remaining Evolent Health position as of Q3 2017 after selling out during the quarter.
  • ETF Managers Group sold 4,013 Evolent Health shares in Q3 2017, an estimated $102K.
  • ETF Managers Group first reported a position in Evolent Health in Q1 2016 and held it in 2 quarters.
  • ETF Managers Group's Evolent Health position peaked at $102K in Q2 2017.
  • 166 funds tracked by Wall St. Rank held Evolent Health as of Q3 2017.

Based on ETF Managers Group's 13F filing for Q3 2017, filed 14 Nov 2017.